CN1402710A - 抗细小核糖核酸病毒化合物和组合物,其药用,和其合成原料 - Google Patents
抗细小核糖核酸病毒化合物和组合物,其药用,和其合成原料 Download PDFInfo
- Publication number
- CN1402710A CN1402710A CN00816602A CN00816602A CN1402710A CN 1402710 A CN1402710 A CN 1402710A CN 00816602 A CN00816602 A CN 00816602A CN 00816602 A CN00816602 A CN 00816602A CN 1402710 A CN1402710 A CN 1402710A
- Authority
- CN
- China
- Prior art keywords
- carbonyl
- alkyl
- heterocyclylalkyl
- compound
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16898699P | 1999-12-03 | 1999-12-03 | |
| US60/168,986 | 1999-12-03 | ||
| US19205200P | 2000-03-24 | 2000-03-24 | |
| US60/192,052 | 2000-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1402710A true CN1402710A (zh) | 2003-03-12 |
Family
ID=26864652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN00816602A Pending CN1402710A (zh) | 1999-12-03 | 2000-12-01 | 抗细小核糖核酸病毒化合物和组合物,其药用,和其合成原料 |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6514997B2 (https=) |
| EP (1) | EP1252145A1 (https=) |
| JP (1) | JP2003515591A (https=) |
| KR (1) | KR20020058076A (https=) |
| CN (1) | CN1402710A (https=) |
| AP (1) | AP2002002510A0 (https=) |
| AR (1) | AR030540A1 (https=) |
| AU (1) | AU777943B2 (https=) |
| BG (1) | BG106754A (https=) |
| BR (1) | BR0016742A (https=) |
| CA (1) | CA2392504A1 (https=) |
| CO (1) | CO5261566A1 (https=) |
| CZ (1) | CZ20021906A3 (https=) |
| DO (1) | DOP2000000108A (https=) |
| EA (1) | EA200200625A1 (https=) |
| EE (1) | EE200200281A (https=) |
| HK (1) | HK1052933A1 (https=) |
| HU (1) | HUP0204006A3 (https=) |
| IL (1) | IL149427A0 (https=) |
| IS (1) | IS6378A (https=) |
| MX (1) | MXPA02005124A (https=) |
| NO (1) | NO20022589L (https=) |
| NZ (1) | NZ518934A (https=) |
| OA (1) | OA12101A (https=) |
| PA (1) | PA8507801A1 (https=) |
| PE (1) | PE20020157A1 (https=) |
| PL (1) | PL356062A1 (https=) |
| SK (1) | SK7602002A3 (https=) |
| UY (1) | UY26465A1 (https=) |
| WO (1) | WO2001040189A1 (https=) |
| YU (1) | YU40002A (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1073672T3 (da) | 1998-04-30 | 2003-12-08 | Agouron Pharma | Antipicornavirale forbindelser, deres fremstilling og anvendelse |
| PE20011277A1 (es) | 2000-04-14 | 2002-01-07 | Agouron Pharma | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis |
| WO2001096297A2 (en) | 2000-06-14 | 2001-12-20 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| ES2330719T3 (es) * | 2000-12-28 | 2009-12-15 | SHIONOGI & CO., LTD. | Derivados de 2-piridona con afinidad para el receptor cannabinoide de tipo 2. |
| AU2003243657A1 (en) * | 2002-06-26 | 2004-01-19 | Bristol-Myers Squibb Company | Amino-bicyclic pyrazinones and pyridinones |
| EP1606019A1 (en) * | 2003-03-07 | 2005-12-21 | The University Court of The University of Aberdeen | Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders |
| WO2004093860A1 (en) * | 2003-04-21 | 2004-11-04 | Pfizer Inc. | Inhibitors of sars related coronavirus proteinase |
| US20040235952A1 (en) * | 2003-05-05 | 2004-11-25 | Agouron Pharmaceuticals, Inc. | Inhibitors of severe acute respiratory syndrome (SARS) 3C-like proteinase |
| US7462594B2 (en) * | 2003-12-31 | 2008-12-09 | Taigen Biotechnology Co., Ltd. | Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases |
| AU2004312547A1 (en) * | 2003-12-31 | 2005-07-21 | Taigen Biotechnology | Protease inhibitors |
| US7087622B2 (en) | 2004-05-07 | 2006-08-08 | Janssen Pharmaceutica N.V. | Pyridone compounds as inhibitors of bacterial type III protein secreation systems |
| GB0702862D0 (en) * | 2007-02-14 | 2007-03-28 | Univ Aberdeen | Therapeutic compounds |
| KR100891699B1 (ko) | 2007-04-10 | 2009-04-03 | 광주과학기술원 | 7-아미노-4-((ｓ)-3-(4-플루오로페닐)-2-((r)-3-메틸-2-(5-메틸이소옥사졸-3-카복사미도)부탄아미도)프로판아미도)-7-옥소-2-헵테노에이트 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 바이러스성 질환의 예방 및 치료용 약학적 조성물 |
| US8795630B2 (en) * | 2008-08-29 | 2014-08-05 | Treventis Corporation | Butyrylcholinesterase ligands as diagnostic tools and treatment for diseases of the nervous system |
| KR101385855B1 (ko) * | 2012-10-16 | 2014-04-22 | 이동익 | 카뎁신 검출용 다이아로마틱 아미노산 기질 |
| US11021513B2 (en) | 2016-05-13 | 2021-06-01 | Emory University | Peptidomimetics for the treatment of norovirus infection |
| US11124497B1 (en) | 2020-04-17 | 2021-09-21 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| MX2022013081A (es) * | 2020-04-23 | 2022-11-10 | Purdue Research Foundation | Compuestos para el tratamiento de sars. |
| US11174231B1 (en) | 2020-06-09 | 2021-11-16 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| CA3189027A1 (en) | 2020-07-11 | 2022-01-20 | Pfizer Inc. | Antiviral heteroaryl ketone derivatives |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4652676A (en) | 1985-05-06 | 1987-03-24 | General Foods Corporation | L-aminodicarboxylic acid alkenes |
| US5374623A (en) | 1992-08-20 | 1994-12-20 | Prototek, Inc. | Cysteine protease inhibitors effective for in vivo use |
| US5514778A (en) | 1993-07-01 | 1996-05-07 | Eli Lilly And Company | Anti-picornaviral agents |
| US5486623A (en) | 1993-12-08 | 1996-01-23 | Prototek, Inc. | Cysteine protease inhibitors containing heterocyclic leaving groups |
| IL112759A0 (en) | 1994-02-25 | 1995-05-26 | Khepri Pharmaceuticals Inc | Novel cysteine protease inhibitors |
| IT1269511B (it) | 1994-05-17 | 1997-04-01 | Univ Degli Studi Milano | Derivati di acidi ammino-solfonici , loro impiego nella sintesi di pseudopeptidi e procedimento per la loro preparazione |
| US5498616A (en) | 1994-11-04 | 1996-03-12 | Cephalon, Inc. | Cysteine protease and serine protease inhibitors |
| EP0820464A2 (en) | 1995-03-31 | 1998-01-28 | Takeda Chemical Industries, Ltd. | Cysteine protease inhibitor |
| IT1281031B1 (it) | 1995-11-17 | 1998-02-11 | Carlo Chiaves | Struttura prefabbricata per la realizzazione di opere costruite a cielo aperto, particolarmente per cavalcavia autostradali, |
| US5856530A (en) | 1996-05-14 | 1999-01-05 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and methods for their use and preparation |
| ES2242225T3 (es) | 1996-05-14 | 2005-11-01 | Agouron Pharmaceuticals, Inc. | Inhibidores de proteasas 3c antipicornavirales y procedimientos correspondientes de utilizacion y de preparacion. |
| WO1997049668A1 (en) | 1996-06-13 | 1997-12-31 | Smithkline Beecham Corporation | Inhibitiors of cysteine protease |
| PT975588E (pt) | 1997-03-28 | 2004-02-27 | Agouron Pharma | Compostos antipicornavirais, composicoes que os contem e metodos para a sua utilizacao |
| US6020371A (en) | 1997-03-28 | 2000-02-01 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds compositions containing them and methods for their use |
| US6331554B1 (en) | 1997-03-28 | 2001-12-18 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds, compositions containing them, and methods for their use |
| US5962487A (en) | 1997-12-16 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and methods for their use and preparation |
| DK1073672T3 (da) * | 1998-04-30 | 2003-12-08 | Agouron Pharma | Antipicornavirale forbindelser, deres fremstilling og anvendelse |
| US6369226B1 (en) | 1999-06-21 | 2002-04-09 | Agouron Pharmaceuticals, Inc. | Substituted benzamide inhibitors of rhinovirus 3C protease |
| AU779321B2 (en) | 1999-08-04 | 2005-01-20 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| AU778062B2 (en) | 1999-08-24 | 2004-11-11 | Agouron Pharmaceuticals, Inc. | Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
| PE20010517A1 (es) | 1999-08-24 | 2001-05-16 | Agouron Pharma | Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus y los intermedios claves |
-
2000
- 2000-11-30 PE PE2000001276A patent/PE20020157A1/es not_active Application Discontinuation
- 2000-11-30 PA PA20008507801A patent/PA8507801A1/es unknown
- 2000-12-01 HK HK03104911.5A patent/HK1052933A1/zh unknown
- 2000-12-01 YU YU40002A patent/YU40002A/sh unknown
- 2000-12-01 IL IL14942700A patent/IL149427A0/xx unknown
- 2000-12-01 DO DO2000000108A patent/DOP2000000108A/es unknown
- 2000-12-01 MX MXPA02005124A patent/MXPA02005124A/es not_active Application Discontinuation
- 2000-12-01 WO PCT/US2000/032621 patent/WO2001040189A1/en not_active Ceased
- 2000-12-01 PL PL00356062A patent/PL356062A1/xx not_active Application Discontinuation
- 2000-12-01 KR KR1020027007099A patent/KR20020058076A/ko not_active Withdrawn
- 2000-12-01 AU AU18094/01A patent/AU777943B2/en not_active Ceased
- 2000-12-01 EE EEP200200281A patent/EE200200281A/xx unknown
- 2000-12-01 CZ CZ20021906A patent/CZ20021906A3/cs unknown
- 2000-12-01 CA CA002392504A patent/CA2392504A1/en not_active Abandoned
- 2000-12-01 AP APAP/P/2002/002510A patent/AP2002002510A0/en unknown
- 2000-12-01 US US09/726,376 patent/US6514997B2/en not_active Expired - Fee Related
- 2000-12-01 CN CN00816602A patent/CN1402710A/zh active Pending
- 2000-12-01 UY UY26465A patent/UY26465A1/es not_active Application Discontinuation
- 2000-12-01 EA EA200200625A patent/EA200200625A1/ru unknown
- 2000-12-01 EP EP00980893A patent/EP1252145A1/en not_active Withdrawn
- 2000-12-01 OA OA1200200160A patent/OA12101A/en unknown
- 2000-12-01 HU HU0204006A patent/HUP0204006A3/hu unknown
- 2000-12-01 BR BR0016742-8A patent/BR0016742A/pt not_active IP Right Cessation
- 2000-12-01 SK SK760-2002A patent/SK7602002A3/sk unknown
- 2000-12-01 NZ NZ518934A patent/NZ518934A/en unknown
- 2000-12-01 JP JP2001541874A patent/JP2003515591A/ja not_active Withdrawn
- 2000-12-04 AR ARP000106412A patent/AR030540A1/es unknown
- 2000-12-04 CO CO00092264A patent/CO5261566A1/es not_active Application Discontinuation
-
2002
- 2002-05-10 IS IS6378A patent/IS6378A/is unknown
- 2002-05-30 BG BG106754A patent/BG106754A/bg unknown
- 2002-05-31 NO NO20022589A patent/NO20022589L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003515591A (ja) | 2003-05-07 |
| PL356062A1 (en) | 2004-06-14 |
| EE200200281A (et) | 2003-06-16 |
| SK7602002A3 (en) | 2003-02-04 |
| HK1052933A1 (zh) | 2003-10-03 |
| NO20022589L (no) | 2002-07-31 |
| DOP2000000108A (es) | 2003-03-15 |
| US20010047006A1 (en) | 2001-11-29 |
| AP2002002510A0 (en) | 2002-06-30 |
| IS6378A (is) | 2002-05-10 |
| NZ518934A (en) | 2003-11-28 |
| PA8507801A1 (es) | 2002-08-26 |
| BR0016742A (pt) | 2002-09-03 |
| AU1809401A (en) | 2001-06-12 |
| AU777943B2 (en) | 2004-11-04 |
| AR030540A1 (es) | 2003-08-27 |
| EP1252145A1 (en) | 2002-10-30 |
| YU40002A (sh) | 2006-01-16 |
| BG106754A (bg) | 2003-07-31 |
| EA200200625A1 (ru) | 2002-12-26 |
| CZ20021906A3 (cs) | 2003-02-12 |
| CA2392504A1 (en) | 2001-06-07 |
| NO20022589D0 (no) | 2002-05-31 |
| OA12101A (en) | 2006-05-04 |
| US6514997B2 (en) | 2003-02-04 |
| IL149427A0 (en) | 2002-11-10 |
| UY26465A1 (es) | 2001-06-29 |
| WO2001040189A1 (en) | 2001-06-07 |
| HUP0204006A3 (en) | 2004-11-29 |
| MXPA02005124A (es) | 2003-01-28 |
| CO5261566A1 (es) | 2003-03-31 |
| PE20020157A1 (es) | 2002-02-22 |
| KR20020058076A (ko) | 2002-07-12 |
| HUP0204006A2 (hu) | 2003-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1402710A (zh) | 抗细小核糖核酸病毒化合物和组合物,其药用,和其合成原料 | |
| CN100338044C (zh) | Hiv蛋白酶抑制剂、含有它们的组合物、其药物应用及其合成原料 | |
| CN1198838C (zh) | 抗小rna病毒化合物及其制备方法和用途 | |
| CN1088706C (zh) | 新型杂环酰胺化合物及其医药用途 | |
| CN1290825C (zh) | 邻位、间位取代的双芳基化合物、它们的制备方法、它们作为药物的用途和含有它们的药物制剂 | |
| CN1221529C (zh) | 取代的n－[(氨基亚氨基甲基或氨甲基)苯基]丙基酰胺 | |
| CN1098263C (zh) | 吡啶－2－基－甲胺衍生物、其制备方法及其作为药物的用途 | |
| CN1101380C (zh) | 作为法尼基转移酶抑制剂的4－巯基吡咯烷衍生物 | |
| CN1160343C (zh) | 依赖于细胞周期蛋白激酶的氨基噻唑抑制剂 | |
| CN1483024A (zh) | Vla-4抑制剂 | |
| CN1441783A (zh) | 含二氰基吡啶衍生物的药物 | |
| CN1688548A (zh) | 喹啉抗生素中间体的制备方法 | |
| CN1859904A (zh) | 用于治疗阿尔茨海默氏病的苄醚和苄氨基β－分泌酶抑制剂 | |
| CN1395562A (zh) | 含氮的环状化合物及含有该化合物的药物组合物 | |
| CN1845921A (zh) | 金刚烷和氮杂双环－辛烷及壬烷衍生物、其制备方法及其作为dpp－iv抑制剂的用途 | |
| CN1537102A (zh) | 用作钾通道抑制剂的邻位取代的含氮双芳基化合物 | |
| CN1812972A (zh) | 天冬氨酸特异性半胱氨酸蛋白酶抑制剂及其用途 | |
| CN1227238C (zh) | 作为抗菌剂的哌啶氧基和吡咯烷氧基苯基噁唑烷酮 | |
| CN1741990A (zh) | 芳基烷基氨基甲酸酯衍生物的生产及其在治疗中的用途 | |
| CN1332727A (zh) | 3,3－二芳基哌啶和2,2－二芳基吗啉衍生物 | |
| HK1042691A1 (zh) | 磺酰胺异羟肟酸脂 | |
| CN1556788A (zh) | 毒蕈碱受体激动剂 | |
| CN1934097A (zh) | 炔基化哌嗪化合物及其作为代谢型谷氨酸受体拮抗剂的应用 | |
| CN1431995A (zh) | 抗细小rna病毒的化合物与组合物,它们的药物用途,以及用于其合成的物质 | |
| CN1237962A (zh) | 作为k激动剂的吡咯烷基和吡咯啉基乙胺化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| AD01 | Patent right deemed abandoned | ||
| C20 | Patent right or utility model deemed to be abandoned or is abandoned | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1052933 Country of ref document: HK |